Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
What's in Store for Gilead (GILD) This Earnings Season?
02:18pm, Tuesday, 25'th Oct 2022
Investors focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports third-quarter 2022 results.
Gilead (GILD) Inks Deal for Gene Platform in Blood Cancers
01:33pm, Friday, 21'st Oct 2022
Gilead (GILD) signs a license agreement with Refuge Biotechnologies to use the latter's gene expression platform to develop treatments for blood cancers.
Gilead's (GILD) Yescarta Gets EC Nod for New Cancer Indication
02:18pm, Tuesday, 18'th Oct 2022
The European Commission approves Gilead's (GILD) CAR T-cell therapy, Yescarta, for treating adult patients with second-line diffuse large b-cell lymphoma and high-grade b-cell lymphoma.
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
06:41am, Sunday, 16'th Oct 2022
All three of these medical stocks offer a high-yield dividend.
Gilead's Quality And Growth Potential Are Underappreciated
09:19am, Friday, 14'th Oct 2022
Gilead is a high-quality pharma company with a protected market position trading significantly below its fair value. The market seems to misunderstand or underappreciate Gilead's growth potential due
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
10:32am, Thursday, 13'th Oct 2022
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Gilead Stock Delivers Stable Dividend In Hot Biotech Sector
01:29pm, Wednesday, 12'th Oct 2022
The established nature of Gilead's business allows the company to pay out a strong dividend, currently yielding 4.2%. The post Gilead Stock Delivers Stable Dividend In Hot Biotech Sector appeared firs
4 Biotech Stocks With Huge Incoming Catalysts
05:29am, Wednesday, 12'th Oct 2022
All four of these drugmakers are expecting important FDA approval decisions over the next few months.
Gilead (GILD) Up 2.6% in 3 Months: Will the Momentum Continue?
01:32pm, Monday, 10'th Oct 2022
Gilead (GILD) is having a good run despite the volatility on a string of positive updates.
Should I invest in Viatris shares after the current dip?
08:21am, Saturday, 08'th Oct 2022
Viatris Inc. (NASDAQ: VTRS) shares have weakened from $10.20 to $8.42 since September 12, 2022, and the current price stands at $8.74. The U.S. stock market remains under pressure, and going forward,
Gilead stock price ‘does not' reflect its oncology business: Analyst
08:19pm, Tuesday, 04'th Oct 2022
Gilead Sciences Inc (NASDAQ: GILD) ended in the green on Tuesday after a JPMorgan analyst turned bullish on the biopharmaceutical company. Gilead stock should be worth $80 a share Chriss Schott now ra
Gilead Sciences: Becoming A Cure
07:49am, Monday, 03'rd Oct 2022
Gilead Sciences has seen a solid second quarter, with non-Covid-19 related product sales being relatively strong. The company has been pursing some bolt-on deals in the meantime, nothing which moves t
2 Top Biotech Stocks to Buy for the Long Haul
10:00am, Sunday, 02'nd Oct 2022
Both drugmakers have outperformed the stock market this year.
7 Monthly Dividend Stocks to Buy for Safety
06:45am, Thursday, 29'th Sep 2022
The best safe monthly dividend stocks are remarkably compelling during the current market downturn. However, many top dividend stocks have also taken a sizeable hit in value over the past several mont
Gilead widens battle against alleged counterfeit HIV drug ring
08:12pm, Wednesday, 28'th Sep 2022
A federal judge in New York has frozen the assets of dozens of people and entities accused of operating a massive nationwide scheme to distribute counterfeit bottles of Gilead Sciences Inc HIV drugs,
